RecruitingNot ApplicableNCT06253858

Ultrasound (US) Guided External Ventricular Catheter Placement


Sponsor

Milton S. Hershey Medical Center

Enrollment

10 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.


Eligibility

Min Age: 18 Years

Inclusion Criteria8

  • Decision made to perform the procedure by the primary consultant
  • Age 18 or older
  • Neuro ICU stay
  • Newly diagnosed hydrocephalus
  • Has a recent CT within the past 24 hrs
  • Normal platelets and coagulation profile
  • No active infection or currently on antibiotics
  • The targeted fluid compartment has more than 50 percent CSF vs blood by CT scan imaging

Exclusion Criteria5

  • Age <18
  • Not in Neuro ICU setting
  • Previous placement of a ventricular catheter
  • More than 50 percent of the fluid compartment is filled with blood by CT scan
  • Time to include in the trial prohibited by clinical personnel

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECatheter Placement with Solopass System

This device is used as a guidance for placing a brain catheter to target the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.


Locations(1)

Penn State Health Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06253858


Related Trials